Markus E. Diefenbacher
- Oncology top 5%
- Cancer-related Molecular Pathways 10
- Peptidase Inhibition and Analysis 5
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 16
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 5
- DNA Repair Mechanisms 4
- Cancer-related gene regulation 4
- Cancer Research top 10%
- Cell Biology top 10%
-
- Genetics and Neurodevelopmental Disorders 4
Markus E. Diefenbacher
41 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Oncology 567
- Molecular Biology 1.4k
- Cancer Research 296
- Cell Biology 212
- Immunology 186
Countries citing papers authored by Markus E. Diefenbacher
This map shows the geographic impact of Markus E. Diefenbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus E. Diefenbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus E. Diefenbacher more than expected).
Fields of papers citing papers by Markus E. Diefenbacher
This network shows the impact of papers produced by Markus E. Diefenbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus E. Diefenbacher. The network helps show where Markus E. Diefenbacher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus E. Diefenbacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 29 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 43 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 60 | |
| 14 | 2018 | 27 | |
| 15 | 2015 | 60 | |
| 16 | 2015 | 30 | |
| 17 | 2014 | 13 | |
| 18 | 2012 | 77 | |
| 19 | 2012 | 215 | |
| 20 | 2011 | 35 |
About Markus E. Diefenbacher
Markus E. Diefenbacher is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 42 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (10 papers), RNA modifications and cancer (7 papers), Peptidase Inhibition and Analysis (5 papers), Epigenetics and DNA Methylation (5 papers), DNA Repair Mechanisms (4 papers), Cancer-related gene regulation (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). The work is most often cited by research in Oncology (567 citations), Molecular Biology (1.4k citations) and Cancer Research (296 citations). Markus E. Diefenbacher has collaborated with scholars based in Germany, United Kingdom and Spain. Frequent co-authors include Axel Behrens, Julian Downward, Gordon Stamp, Madhu Kumar, Emma Nye, Atanu Chakraborty, Martin Eilers, Olivier Kassel, Nikita Popov and Rocı́o Sancho. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.